Signifier Medical Technologies closes an oversubscribed Series B round led by The Pritzker Organization to advance sleep disorder treatments.
The Series B round was led by The Pritzker Organization to fund clinical trials and commercial preparation.
Signifier Medical Technologies is a medical technology company that develops patient-friendly therapies for sleep-disordered breathing. Founded in 2015, the firm provides non-invasive solutions to address the root causes of conditions such as obstructive sleep apnoea and primary snoring.
Signifier Medical Technologies has closed an oversubscribed Series B round to support its research and commercial preparations. The funding was led by The Pritzker Organization, with participation from Robert Parkinson Jr and existing board members and founders. The capital will fund ongoing clinical trials, regulatory approvals in the United States, product expansion, and team growth.
From the founder
"Signifier Medical Technologies is aspiring to revolutionize the sleep market"
Anshul Sama
Chief Medical Officer at Signifier Medical Technologies
Investor perspective
"We are excited to support Signifier Medical Technologies in bringing its highly promising new technology to the market to address snoring, a significant health and lifestyle problem for so many people."
Joseph Gleberman
Managing Director, The Pritzker Organization
Use of funds
- 01Fund research and development
- 02Continue product development
- 03Grow the team
Investors
Categories
About the company
Signifier Medical Technologies
Signifier Medical Technologies develops non-invasive therapies for sleep-disordered breathing.